Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionVFSNX - Vanguard FTSE All-World ex-US Small-Cap Index Fund Institutional Shares
Latest Disclosed Ownership89,260 shares
Latest Disclosed Value $ 715,677
VFSNX - Vanguard FTSE All-World ex-US Small-Cap Index Fund Institutional Shares ownership in 4577 / Daito Pharmaceutical Co.,Ltd.

On June 26, 2026 - VFSNX - Vanguard FTSE All-World ex-US Small-Cap Index Fund Institutional Shares filed a NPORT-P form disclosing ownership of 89,260 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $112,556,860 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 31, 2026 disclosing 89,260 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $121,036,560 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-26 2026-04-30 NP DAITO PHARMA EC JP3486150000 89,260 0 0.00 716 -7.14 0.0052
2026-03-31 2026-01-31 NP DAITO PHARMA EC JP3486150000 89,260 -11,300 -11.24 771 -5.06 0.0058
2025-12-23 2025-10-31 NP DAITO PHARMA EC JP3486150000 100,560 24,200 31.69 811 32.95 0.0068
2025-09-25 2025-07-31 NP DAITO PHARMA EC JP3486150000 76,360 22,230 41.07 610 -22.69 0.0054
2025-06-30 2025-04-30 NP DAITO PHARMA EC JP3486150000 54,130 0 0.00 789 9.28 0.0077
2025-03-31 2025-01-31 NP DAITO PHARMA EC JP3486150000 54,130 0 0.00 723 -8.61 0.0069
2024-12-27 2024-10-31 NP DAITO PHARMA EC JP3486150000 54,130 0 0.00 791 -8.56 0.0073
2024-09-27 2024-07-31 NP DAITO PHARMA EC JP3486150000 54,130 -8,900 -14.12 865 -14.12 0.0081
2024-06-27 2024-04-30 NP DAITO PHARMA EC JP3486150000 63,030 0 0.00 1,006 19.62 0.0101
2024-04-01 2024-01-31 NP DAITO PHARMA EC JP3486150000 63,030 0 0.00 841 4.47 0.0081
2023-12-28 2023-10-31 NP DAITO PHARMA EC JP3486150000 63,030 5,730 10.00 805 -14.63 0.0089
2023-09-29 2023-07-31 NP DAITO PHARMA EC JP3486150000 57,300 0 0.00 943 -11.54 0.0086
2023-06-29 2023-04-30 NP DAITO PHARMA EC JP3486150000 57,300 4,500 8.52 1,066 -0.28 0.0104
2023-03-31 2023-01-31 NP DAITO PHARMA EC JP3486150000 52,800 6,300 13.55 1,069 33.79 0.0105
2022-12-28 2022-10-31 NP DAITO PHARMA EC JP3486150000 46,500 -1,800 -3.73 800 -16.68 0.0095
2022-09-29 2022-07-31 NP DAITO PHARMA EC JP3486150000 48,300 4,100 9.28 959 8.48 0.0100
2022-06-29 2022-04-30 NP DAITO PHARMA EC JP3486150000 44,200 13,300 43.04 884 18.02 0.0089
2022-04-01 2022-01-31 NP DAITO PHARMA EC JP3486150000 30,900 0 0.00 750 -14.01 0.0067
2021-12-30 2021-10-31 NP DAITO PHARMA EC JP3486150000 30,900 0 0.00 871 -7.04 0.0073
2021-09-29 2021-07-31 NP DAITO PHARMA EC JP3486150000 30,900 0 0.00 938 -4.39 0.0080
2021-06-29 2021-04-30 NP DAITO PHARMA EC JP3486150000 30,900 0 0.00 980 -10.34 0.0087
2021-04-01 2021-01-31 NP DAITO PHARMA EC JP3486150000 30,900 -1,000 -3.13 1,093 -10.26 0.0143
2020-12-29 2020-10-31 NP DAITO PHARMA EC JP3486150000 31,900 700 2.24 1,219 31.68 0.0197
2020-09-29 2020-07-31 NP DAITO PHARMA EC JP3486150000 31,200 31,200 925 0.0144
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.